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Introduction
A suitable nutrient-based medium is always required for the growth of cells. All cells do 
not have the same requirements for growth and survival. In this aspect, for successful 
growth, maintenance and expression of differentiated metabolic functions in vitro, an 
appropriate culture conditions are required, which mimic the physiological conditions in 
vivo and in situ. In fact, it is well known that, serum supplement like fetal bovine serum 
(FBS) represents a fundamental source of nutrients, cytokines, and adhesive molecules 
necessary for in vitro cell growth, metabolism, and to stimulate the cell proliferation[1,2]. 
In general circumstance, an alteration of an immune system in any living system is 
mediated through the secretion of key cytokines such as tumor necrosis factor - alpha 
(TNF-α), interleukin (IL)-1β, and macrophage inflammatory protein (MIP)-1α. Thy-
mus derived lymphocyte helper cell 1 (TH1) is the primary sources for IL-1β, TNF-α, 
IL-2, interferon-ϒ (IFN-ϒ), lymphotoxins and other factors, which characterize the 
cell-mediated immune responses[3]. The different type of immune cells such as dendrit-
ic cells (DCs), macrophages, and spleen can play as an important role in order to stop 
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Abstract
The objective of the present study was to evaluate the immunomodulatory effect of Biofield Energy Treatment (The 
Trivedi Effect®) on Dulbecco’s Modified Eagle’s Medium (DMEM) and fetal bovine serum (FBS) in murine macro-
phage cells (RAW 264.7). The study parameters were evaluated using cell viability by MTT assay and estimation of 
proinflammatory cytokine like tumor necrosis factor - alpha (TNF-α) on immunomodulation using enzyme linked 
immune sorbent assay (ELISA). The cell viability using MTT assay data showed that more than 80 % cell viability 
was observed in all the tested groups compared to the baseline control group (G1). The characteristics of cell morphol-
ogy in the Biofield Energy Treated DMEM without FBS (G6) group showed some changes in the cell morphology as 
evidenced a transition from spherical to elongate and also showed maturation compared to the G1 group. The level of 
TNF-α expression was significantly reduced by 23.15 % in the G3 group compared to the G1 group. Moreover, the se-
cretion of TNF-α was altered by 38.06 %, 35.77 %, and 282.49 % in the G4, G5, and G6 groups, respectively compared 
to the G1 group. The overall results demonstrated that the Trivedi Effect® - Consciousness Energy Healing Treatment 
has an impact on DMEM and FBS by alteration of cell morphology and reducing the level of TNF-α expression in 
immune cell (RAW 264.7). Therefore, the Trivedi Effect® treated DMEM and FBS might be useful as an immunomod-
ulator for various immune-related disorders like Graves’ disease, rheumatoid arthritis, multiple sclerosis, etc.
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the acute/chronic inflammation and retrieve a steady state strat-
egy through the secretion of immuno-modulating cytokines[4]. 
In this study, the cytotoxic effect of the Biofield Energy Treated 
medium and FBS was screened by assessing the metabolic ac-
tivity of immune cells using MTT assay. MTT assay is rapid, 
cost-effective, less time consuming, and non-radioactive type 
of method, which was previously proven to show the similar 
pattern of result in cell proliferation as the bromodeoxyuridine 
(BrdU) assay[5]. In the current global scenario, Energy Therapy 
like Biofield Energy Healing has been widely used and recom-
mended as an alternative method that has an impact on various 
properties of living organisms in a cost-effective manner[6]. The 
Trivedi Effect® - Biofield Energy Healing has been known to 
improve the potential beneficial effects in a broad spectrum field 
around the Globe. It improved the overall productivity of crops 
in agriculture and livestoc[7-10], positive impact on cancer[11,12], 
and altered characteristics features of microbes in the field of 
microbiology[13-16]. It also altered the structural, physical, and 
thermal properties of several metals and ceramics [17-19], caus-
es chromosomal changes in microbes[20,21], and improved vari-
ous nutraceutical compounds in the areas of nutraceuticals[22,23] 
and biotechnology[24-26]. Many therapeutic aspects are available 
for the proliferation and differentiation of macrophages cells 
by means of some chemical treatment. The aim of the present 
study was to develop a potential culture medium for the efficient 
growth and differentiation of macrophage cells (RAW 264.7). 
The macrophages (RAW 264.7) culture and to investigate the 
influence of Biofield Energy Treated Dulbecco’s Modified Ea-
gle’s Medium (DMEM) and FBS in comparison to cell viability, 
morphology, and estimation of cytokine - TNF-α.
Materials and Methods
Chemicals and reagents
Antibiotics solution (penicillin-streptomycin) and DMEM (phe-
nol-red free) were procured from HiMedia, India. DMEM was 
procured from GIBCO, USA. Direct Red 80, 3-(4, 5-dimeth-
yl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium) (MTT), and li-
popolysaccharide (LPS; positive control) were purchased from 
Sigma Chemical Co. St. Louis, MO, USA. All the other chemi-
cals used in this experiment were analytical grade procured from 
the India.
Cell culture and maintenance
Murine macrophage cell line, RAW 264.7 was procured from 
The National Centre for Cell Science (NCCS), Pune, India, used 
as the test system in the present study. Macrophage cell line was 
maintained under DMEM supplemented with 10 % FBS for rou-
tine culture. Growth conditions were maintained at 37°C, 5 % 
CO2, and 95 % humidity and sub-cultured by tapping the flask 
and splitting the cell suspension into fresh flasks and supple-
menting with fresh cell growth medium.
Biofield energy treatment modalities
The DMEM growth medium and FBS were subjected to Biofield 
Energy Treatment (The Trivedi Effect®) under standard labora-
tory conditions for ~3 minutes from a distance of ~25 cm. The 
energy transmission was done without touching the medium and 
FBS. Following Biofield Energy Treatment, the DMEM and 
FBS were used for culture of macrophage cells.
Experimental design
The tested cells were divided into seven groups. Group (G) 1 
served as baseline control (untreated DMEM and FBS). G2 
served as positive control (LPS-50 ng/mL). G3 includes Biofield 
Energy Treated FBS with untreated DMEM andG4 contained 
Biofield Energy Treated DMEM with untreated FBSG5 defined 
as both Biofield Energy Treated DMEM and FBSG6 referred as 
Biofield Energy Treated DMEM without FBS andG7 consisted 
with untreated DMEM without FBS. 
Assessment of cell proliferation
Murine macrophage cell line, RAW 264.7 was used in this ex-
periment for the assessment of cell proliferation and morpholo-
gy. The DMEM and FBS were trypsinized, counted, and plated 
in wells of flat bottom 96-well plates at the density correspond-
ing to 5 X 103 cells/well/180 µL of growth medium. Following 
respective treatments, the cells in the 96-well plates were incu-
bated for 48 hours in a CO
2
 incubator at 37°C, 5 % CO
2
, and 95 
% humidity. After 48 hours of incubation, the plate was taken 
out and 20 µL of 5 mg/mL of MTT solution was added to all the 
wells followed by additional incubation for 3 hours at 37°C. The 
supernatant was aspirated and 150 µL of DMSO was added to 
each well to dissolve formazan crystals. The absorbance of each 
well was read at 540 nm using Synergy HT microplate reader. 
The percentage cell growth corresponding to each treatment was 
calculated using 
Formula (1):
% Cell growth = [[(X-Tz)/(R-Tz)] x 100]...............................(1)
Where, X = Absorbance of cells corresponding to positive con-
trol and test groups after 48 hours
R = Absorbance of cells corresponding to Baseline group after 
48 hours
Tz = Absorbance of untreated cells at time 0 hour
Effects of Biofield Energy Treatment on Secretion of TNF-α
The effect of the Biofield Energy Treated and untreated DMEM 
and FBS on the production of TNF-α was measured by ELISA 
method using culture supernatants. Briefly, the ELISA plates 
were coated overnight and kept at 4°C with coating buffer con-
taining capture antibody at the recommended concentration. 
After washing with phosphate buffer saline (PBS)-T (PBS with 
0.05 % Tween 20), the plates were blocked with assay diluent 
for at least 2 hours at room temperature (RT). About 100 μL 
of culture supernatant from different experimental samples and 
standards were incubated overnight at 4°C and, after three wash-
es, the biotinylated anti-mouse cytokine (i.e., TNF-α) antibodies 
at the recommended concentrations were incubated for 1 hour, 
at RT and the plate was incubated for 45 minutes at RT with gen-
tle shaking. Plates were again washed 3 times and then 100 μL 
of horseradish per-oxidase (HRP)-streptavidin conjugate solu-
tion was added, and the plate was incubated for 45 minutes at 
RT with gentle shaking in a shaker. Next, the plate wells were 
washed 3 times and 100 μL of 3, 3, 5, 5'-tetramethylbenzidine 
(TMB) was added to the wells followed by 30 minutes incuba-
tion at RT in dark condition. Then 50 μL of 0.2 mol/L sulphuric 
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acid was added to each well to stop the reaction. After that, the 
plates were read for absorbance at 450 nm using a Biotek reader 
(SIAFRT/Synergy HT multimode reader). Positive control was 
run in parallel to the samples. Concentrations were determined, 
and the experiment was done in triplicates.
Statistical analysis
Data analysis was performed with SigmaPlot Statistical Soft-
ware (Version 11.0). Differences between means (in triplicates) 
were assessed for the statistical differences using Student’s t-test 
(between two groups) and for multiple comparison one-way 
analysis of variance (ANOVA) and post-hoc analysis was done 
by Dunnett’s test. P ≤ 0.05 was considered as statistically signif-
icant. The results are shown as mean ± standard error of mean 
(SEM).
Results and Discussion
Assessment of the cells viability by MTT assay and cell mor-
phology
RAW 264.7 cells were exposed with the Biofield Energy Treated 
DMEM and FBS for 24 hours. The cell viability was assessed 
by MTT assay is shown in Figure 1. All the tested groups result-
ed approximately >80 % cell viability compared to the baseline 
control group (G1) and hence, was considered as non-cytotoxic 
for cytokine estimation. Besides, cell morphology is demonstrat-
ed in Figure 2. G1 group (untreated DMEM and FBS) demon-
strated a spherical morphology with semi-adherence to surface, 
which was typical characteristic of RAW264.7 cells G2 group 
(LPS + untreated DMEM + untreated FBS) showed maturation 
of macrophages. Elongated cells attached to surface were ob-
served. Biofield Energy Treated groups such asG3 (untreated 
DMEM + Biofield Energy Treated FBS), G4 (Biofield Energy 
Treated DMEM + untreated FBS), and G5 (Biofield Energy 
Treated DMEM + Biofield Energy Treated FBS) showed no 
significant changes with respect to the control group(G1). Ad-
ditionally,G6 group (Biofield Energy Treated DMEM without 
FBS) showed a changes in cell morphology, like a transition 
from spherical to elongate and attached morphology of cells was 
observed, showing maturation. Further, G7 group (untreated 
DMEM without FBS) showed no significant changes from con-
trol group (Figure 2).
Figure 1: Effect of the Biofield Energy Treatment on the viability of 
RAW264.7 cells measured after 24 hours. G1: Baseline control (un-
treated DMEM and FBS); G2: Positive control (LPS-50 ng/mL); G3: 
Biofield Energy Treated FBS with untreated DMEM; G4: Biofield En-
ergy Treated DMEM with untreated FBS; G5: Both Biofield Energy 
Treated DMEM and FBS; G6: Biofield Energy Treated DMEM without 
FBS; and G7: Untreated DMEM without FBS.
Figure 2: Effect of the Biofield Energy Treatment on cellular morphol-
ogy of RAW264.7 cells captured after 24 hours. BFT: Biofield Energy 
Treatment; LPS (PC): Lipopolysaccharide (positive control).
Effects of the biofield energy treatment on secretion of TNF-α
The effect of the Biofield Energy Treatment on DMEM and FBS 
for the secretion of TNF-α in RAW 264.7 cells is depicted in 
Figure 3. The label of TNF-α was 262.2 ± 13.49 pg/mL in the 
baseline control group (G1). Further, it was significantly (p ≤ 
0.001) increased by 1057.82 % in the positive control (LPS - 50 
ng/mL) group (G2) compared to the G1 group. The expression 
of TNF-α was significantly reduced by 23.15 % (p≤0.01) and 
39.70 % (p≤0.001) in the G3 and G7 groups, respectively with 
respect to the G1 group. Moreover, the secretion of TNF-α was 
altered by 38.06 %, 35.77 %, and 282.49 % in the G4, G5, and 
G6 groups, respectively compared to the G1 group. RAW 264.7 
cells, derived from monocyte/macrophage were cultured in the 
Biofield Energy Treated DMEM and FBS. The concentration of 
TNF-α in cell culture media was determined by ELISA-TNF-α 
immunoassay. In conventional mechanistic aspect, macrophages 
regulates the immune response by releasing proinflammatory 
cytokines such as TNF-α, IL-1, and IL-6. However, overproduc-
tion of these cytokines, became detrimental, which prolonged 
the inflammation and aggravate tissue damage[27-30]. The level of 
TNF-α was remarkably increased in the G2 group compared to 
thesG1 group, which was due to exposure to LPS (viruses or 
bacterial endotoxins). Because the activated macrophages are 
the major source of cytokines and increased the level of cyto-
kine gene expression by LPS and involves the action of several 
families of transcription factors, including members of the nu-
clear factor-κB (NF-κB) and consisting rel protein, CCAAT-en-
hancer-binding proteins (C/EBP), erythroblast transformation- 
specific (Ets) protein, and activator protein 1 (AP-1) families[31]. 
Induction of proinflammatory cytokine expression is critical for 
a rapid response against tissue trauma or infection. For example, 
as TNF-α is too cytotoxic, and increase overexpression causes 
various serious pathological conditions such as septic shock, 
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acute inflammation, cachexia, autoimmune disease, and Alzhei-
mer’s syndrome[32-34]. In United State, approximately 175,000 
deaths had been reported per year due to only septic shock[35]. In 
this experiment, the level of proinflammatory cytokine (TNF-α) 
was significantly reduced by 23.15 % in the Biofield Energy 
Treated FBS group(G3). Rest of the treated groups showed a 
significantly alteration the expression of TNF-α compared to the 
baseline control group (G1). Based on the outcome it is assumed 
that Mr. Trivedi’s Consciousness Energy Healing Treatment has 
an impact on FBS to inhibit the secretion of proinflammatory 
cytokine like TNF-α. Thus, the Biofield Energy Treated FBS 
would be more beneficial to maintain a healthy grown culture 
medium in the areas of in vitro cell culture technique.
Figure 3: Effect of the Biofield Energy Treatment on the secretion 
of TNF-α in RAW264.7 cells measured after 24 hours. G1: Baseline 
control (untreated DMEM and FBS); G2: Positive control (LPS-50 ng/
mL); G3: Biofield Energy Treated FBS and untreated DMEM; G4: Bio-
field Energy Treated DMEM and untreated FBS; G5: Biofield Energy 
Treated DMEM and FBS; G6: Biofield Energy Treated DMEM without 
FBS; and G7: Untreated DMEM without FBS. ***p≤0.001 vs. baseline 
control group-G1 (using one-way ANOVA). **p≤0.01 and ###p≤0.001 
vs. G1 group (using Student’s t-test).
Conclusions
The present study was conducted to evaluate the effect of Bio-
field Energy Treatment (The Trivedi Effect®) on DMEM and 
FBS for the assessment of TNF-α secretion in macrophage cells 
(RAW264.7). All the treatment groups demonstrated no adverse 
effects on cell viability with relation to the baseline control 
group(G1). However, all the tested groups showed >80 % cell 
viability compared to the baseline control group (G1). Besides, 
the Biofield Energy Treated DMEM without FBS group (G6) 
showed some changes in the cell morphology as evidenced a 
transition from spherical to elongate and also showed matura-
tion of cells compared to theG1 group. The level of TNF-α ex-
pression was significantly reduced by 23.15 % in the Biofield 
Energy Treated FBS group(G3) with respect to the G1 group. In 
conclusion, The Trivedi Effect® - Consciousness Energy Healing 
Treatment might impact on DMEM and FBS by alteration of cell 
morphology and reducing the level of TNF-α expression in im-
mune cell (macrophage RAW 264.7). Therefore, it can be useful 
as an immunomodulator for various immune-related disorders 
viz. multiple sclerosis, lupus, vasculitis, scleroderma, various 
types of hemolytic anemia, diabetes (type-1), graves’ disease, 
rheumatoid arthritis, etc. in the near future. 
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